TRANSCRIPCIÓN 🔗
1
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:24,360 --> 00:00:27,330
by Andy Eeckhout from ADVANZ PHARMA,
9
00:00:27,330 --> 00:00:29,760
who's working in Commercial
Excellence there.
10
00:00:29,760 --> 00:00:31,170
Andy, it's a pleasure to have you.
11
00:00:31,170 --> 00:00:32,460
Thank you for joining.
12
00:00:32,460 --> 00:00:33,420
- Thank you. Pleasure.
13
00:00:33,420 --> 00:00:35,040
- Why don't you share a few words
14
00:00:35,040 --> 00:00:38,520
about yourself, what it
is that you're doing,
15
00:00:38,520 --> 00:00:40,170
and how you came to get there.
16
00:00:40,170 --> 00:00:41,130
- Absolutely. Absolutely.
17
00:00:41,130 --> 00:00:43,110
So, thanks again for the invitation.
18
00:00:43,110 --> 00:00:46,740
A little bit about myself.
So, I'm from Belgium.
19
00:00:46,740 --> 00:00:50,730
I have a background master
degree in physical education,
20
00:00:50,730 --> 00:00:53,790
a post-graduate marketing degree.
21
00:00:53,790 --> 00:00:57,570
And then I was, at that
time a football player,
22
00:00:57,570 --> 00:00:59,250
who was really passionate about
23
00:00:59,250 --> 00:01:02,280
and had the chance to
start as a sales rep.
24
00:01:02,280 --> 00:01:04,440
I had a friend, a
teammate that was working
25
00:01:04,440 --> 00:01:05,970
for a pharmaceutical company
26
00:01:05,970 --> 00:01:07,980
and that was talking about that,
27
00:01:07,980 --> 00:01:09,660
and he said, "Maybe
that's something for you.
28
00:01:09,660 --> 00:01:12,660
You're very social, you
like to engage with people."
29
00:01:12,660 --> 00:01:15,180
So, that's how I started working
in a pharmaceutical company
30
00:01:15,180 --> 00:01:17,280
at MSD at the time.
31
00:01:17,280 --> 00:01:19,710
So, I started as a sales rep,
32
00:01:19,710 --> 00:01:23,520
became at quite early age,
district manager, sales manager,
33
00:01:23,520 --> 00:01:26,280
national manager, business unit director.
34
00:01:26,280 --> 00:01:30,690
And then I worked for a couple
of companies last 22 years.
35
00:01:30,690 --> 00:01:33,060
So, I think, I've seen a
lot of therapeutic areas.
36
00:01:33,060 --> 00:01:35,820
I've seen a lot of layers in the business,
37
00:01:35,820 --> 00:01:38,217
a lot of departments, so, yeah.
38
00:01:38,217 --> 00:01:41,790
So, it's a nice, nice place to
be at now in my career. Yeah.
39
00:01:41,790 --> 00:01:42,990
- Okay. A nice story.
40
00:01:42,990 --> 00:01:47,250
Now, a football colleague
brought you into pharma.
41
00:01:47,250 --> 00:01:50,820
What made you stay? What tickles you?
42
00:01:50,820 --> 00:01:54,510
- Yeah. Quite quickly,
I was intrigued by it.
43
00:01:54,510 --> 00:01:56,040
First of all, I must say at that time,
44
00:01:56,040 --> 00:01:59,340
MSD was a great starting point.
45
00:01:59,340 --> 00:02:02,820
You're really well educated,
so you learn in depth
46
00:02:02,820 --> 00:02:05,700
all about the therapeutic
areas you represent,
47
00:02:05,700 --> 00:02:08,940
but they also teach you how
to engage with physicians.
48
00:02:08,940 --> 00:02:11,010
And at that time, that was new for me.
49
00:02:11,010 --> 00:02:14,280
For me, a physician was, yeah,
somebody really important
50
00:02:14,280 --> 00:02:17,610
and maybe I would've be
afraid to reach out to him,
51
00:02:17,610 --> 00:02:19,770
but we were really well trained on that.
52
00:02:19,770 --> 00:02:21,450
And that's from the
beginning, those engagements
53
00:02:21,450 --> 00:02:25,050
with physicians was
fascinating, especially
54
00:02:25,050 --> 00:02:28,260
at the point where you
discuss really about patients
55
00:02:28,260 --> 00:02:30,117
and the issues they have,
56
00:02:30,117 --> 00:02:33,090
and the solutions we can propose there.
57
00:02:33,090 --> 00:02:35,100
And at some point you realize
58
00:02:35,100 --> 00:02:37,830
that you don't have
only a commercial role,
59
00:02:37,830 --> 00:02:39,840
but you also impact patient's life.
60
00:02:39,840 --> 00:02:44,040
And I think that was maybe the
most motivating factor. Yeah.
61
00:02:44,040 --> 00:02:46,680
- And made you stay in this
nice industry for quite a while.
62
00:02:46,680 --> 00:02:48,150
- Yeah.
- Okay.
63
00:02:48,150 --> 00:02:49,830
Now, at ADVANZ PHARMA, you're responsible
64
00:02:49,830 --> 00:02:51,390
for commercial excellence.
65
00:02:51,390 --> 00:02:52,800
- Yeah.
66
00:02:52,800 --> 00:02:57,510
- It's a buzzword almost
that we hear very often.
67
00:02:57,510 --> 00:02:58,343
- Yeah.
68
00:02:58,343 --> 00:03:00,570
- What does it mean to
you, Commercial Excellence?
69
00:03:00,570 --> 00:03:01,920
- Yeah, first of all,
to be really precise,
70
00:03:01,920 --> 00:03:04,710
I'm part of the Commercial
Excellence team.
71
00:03:04,710 --> 00:03:07,080
I think we have a fantastic
team that was, yeah,
72
00:03:07,080 --> 00:03:10,350
very, very recently built.
73
00:03:10,350 --> 00:03:14,280
I'm particularly responsible
for CRM and Digital Solutions
74
00:03:14,280 --> 00:03:16,803
as part of that Commercial
Excellence team.
75
00:03:17,730 --> 00:03:20,580
I think as a commercial
team, we do so much.
76
00:03:20,580 --> 00:03:23,220
We are in the luxury
position at ADVANZ PHARMA
77
00:03:23,220 --> 00:03:25,110
to launch a lot of products.
78
00:03:25,110 --> 00:03:28,830
We have a great pipeline,
a lot of upcoming launches.
79
00:03:28,830 --> 00:03:32,910
So, Commercial Excellence for
me is all the work to be ready
80
00:03:32,910 --> 00:03:33,743
- Yeah.
81
00:03:33,743 --> 00:03:35,460
- To start promoting the product.
82
00:03:35,460 --> 00:03:37,950
Load full transcript
And as from that point
also to keep on supporting
83
00:03:37,950 --> 00:03:40,874
the local teams, yeah.
84
00:03:40,874 --> 00:03:42,960
- What are some of the ingredients
85
00:03:42,960 --> 00:03:44,730
for achieving commercial excellence?
86
00:03:44,730 --> 00:03:47,340
What do you need in your perspective
87
00:03:47,340 --> 00:03:49,170
to actually make that a reality?
88
00:03:49,170 --> 00:03:52,740
- Yeah, I think, first the
cross-functional aspect.
89
00:03:52,740 --> 00:03:55,800
You sit together with a broader team
90
00:03:55,800 --> 00:03:57,903
to define your strategy.
91
00:03:58,740 --> 00:04:02,070
I mean, from market
access to the marketing,
92
00:04:02,070 --> 00:04:04,140
a lot of interactions with medical
93
00:04:04,140 --> 00:04:05,820
because most of the time they do a lot
94
00:04:05,820 --> 00:04:08,070
of pre-launch activities.
95
00:04:08,070 --> 00:04:10,710
And based on all this information,
you really sit together
96
00:04:10,710 --> 00:04:15,210
as a group and you build
that strategy together,
97
00:04:15,210 --> 00:04:20,210
really top line and then
to the, yeah, tactics.
98
00:04:20,520 --> 00:04:22,290
So, yeah.
- Okay.
99
00:04:22,290 --> 00:04:24,210
Now, it be a miss if I didn't ask,
100
00:04:24,210 --> 00:04:26,370
because Veeva is a technology
company, as you know.
101
00:04:26,370 --> 00:04:29,400
What role you think does technology play
102
00:04:29,400 --> 00:04:31,020
in achieving commercial excellence
103
00:04:31,020 --> 00:04:33,150
or in supporting it, enabling it?
104
00:04:33,150 --> 00:04:36,843
- Yeah, I think a really
important role more than ever.
105
00:04:38,970 --> 00:04:41,030
I don't wanna talk about
too much about COVID,
106
00:04:41,030 --> 00:04:44,280
but I think COVID changed it drastically.
107
00:04:44,280 --> 00:04:48,660
Prior to COVID, I think
technology was important.
108
00:04:48,660 --> 00:04:50,940
First thing comes in my
mind is the CRM system.
109
00:04:50,940 --> 00:04:54,600
You want to keep track of all
the information you gather.
110
00:04:54,600 --> 00:04:56,940
And for us, CRM was very crucial.
111
00:04:56,940 --> 00:05:00,330
There are also other data
management systems, of course,
112
00:05:00,330 --> 00:05:02,280
for other sources of data.
113
00:05:02,280 --> 00:05:05,400
But talking about technology,
COVID completely changed that,
114
00:05:05,400 --> 00:05:08,010
I think, as a lot of
pharmaceutical companies were
115
00:05:08,010 --> 00:05:10,260
in situation that, okay,
we need to find other ways
116
00:05:10,260 --> 00:05:12,120
to interact because we
cannot interact face
117
00:05:12,120 --> 00:05:13,830
to face with them anymore.
118
00:05:13,830 --> 00:05:16,230
So, I think then technology was crucial
119
00:05:16,230 --> 00:05:19,230
to find other channels
to interact with them.
120
00:05:19,230 --> 00:05:20,310
I must say with Veeva,
121
00:05:20,310 --> 00:05:22,350
it was great partnering on that aspect
122
00:05:22,350 --> 00:05:24,360
to explore
all opportunities there.
123
00:05:24,360 --> 00:05:26,850
So, and they could also
share honest feedback
124
00:05:26,850 --> 00:05:31,563
of the expertise of other
companies, so was a good period.
125
00:05:33,120 --> 00:05:35,190
- You mentioned before ADVANZ PHARMA
126
00:05:35,190 --> 00:05:37,980
and kind of the strong launch pipeline
127
00:05:37,980 --> 00:05:38,813
that you're looking at,
128
00:05:38,813 --> 00:05:40,583
which is a good situation-
- Yeah, absolutely.
129
00:05:40,583 --> 00:05:41,940
- To be in, I guess.
- Absolutely.
130
00:05:41,940 --> 00:05:44,790
- But tell us first of all a
bit more about ADVANZ PHARMA
131
00:05:44,790 --> 00:05:46,920
and kind of what's the story?
132
00:05:46,920 --> 00:05:49,860
- Yeah, absolutely. Yeah,
it's a unique story.
133
00:05:49,860 --> 00:05:52,530
I think I've worked now
with a few companies
134
00:05:52,530 --> 00:05:57,530
from big to startups and
ADVANZ is really unique.
135
00:05:57,600 --> 00:06:00,360
So, originally was a generics company,
136
00:06:00,360 --> 00:06:02,460
but last couple of years that, yeah,
137
00:06:02,460 --> 00:06:04,290
whole approach has changed completely.
138
00:06:04,290 --> 00:06:06,930
So, it's now fully into
innovative medicines,
139
00:06:06,930 --> 00:06:10,500
specialized generics,
biosimilars, rare diseases.
140
00:06:10,500 --> 00:06:14,400
So, it becomes, yeah, a
very interesting company
141
00:06:14,400 --> 00:06:16,500
even more than before.
142
00:06:16,500 --> 00:06:19,440
But it's very complex also.
143
00:06:19,440 --> 00:06:23,040
So, we are in a luxury position,
but it's also very complex
144
00:06:23,040 --> 00:06:26,820
because you launch
products in multiple areas,
145
00:06:26,820 --> 00:06:29,910
in areas where you have
already expertise in,
146
00:06:29,910 --> 00:06:32,880
but also in others
where it's really, yeah,
147
00:06:32,880 --> 00:06:34,260
about exploring everything.
148
00:06:34,260 --> 00:06:36,660
So, that makes it interesting
149
00:06:36,660 --> 00:06:39,180
but complex and challenging sometimes.
150
00:06:39,180 --> 00:06:41,640
- Okay, but definitely a success
151
00:06:41,640 --> 00:06:43,983
and growth story that advances writing.
152
00:06:45,000 --> 00:06:48,120
Now, let's talk a little bit
about that launch aspect-
153
00:06:48,120 --> 00:06:49,773
- Yeah.
- Of ADVANZ PHARMA,
154
00:06:51,000 --> 00:06:53,340
because you have launched
quite a few assets
155
00:06:53,340 --> 00:06:56,040
in the recent past and you are going
156
00:06:56,040 --> 00:06:59,280
to launch even more in the
foreseeable future now,
157
00:06:59,280 --> 00:07:02,550
and that includes, as you
said, a very broad variety
158
00:07:02,550 --> 00:07:05,100
of products from generics
through biosimilars,
159
00:07:05,100 --> 00:07:06,099
but also to rare diseases.
160
00:07:06,099 --> 00:07:07,053
- Yeah.
- Right?
161
00:07:08,490 --> 00:07:11,250
What are some of the
ways that you're trying
162
00:07:11,250 --> 00:07:14,430
to meet the unique
challenges of, for example,
163
00:07:14,430 --> 00:07:15,270
the rare disease space,
164
00:07:15,270 --> 00:07:17,100
which is an area you haven't been playing-
165
00:07:17,100 --> 00:07:18,060
- Yeah.
- In the past, right?
166
00:07:18,060 --> 00:07:21,030
And which is very peculiar
in the requirements
167
00:07:21,030 --> 00:07:22,710
and very different to, I guess,
168
00:07:22,710 --> 00:07:23,880
what the other areas-
- Yeah.
169
00:07:23,880 --> 00:07:24,713
- You've been launching
170
00:07:24,713 --> 00:07:26,160
in the past are?
- Yeah.
171
00:07:26,160 --> 00:07:28,290
- So, help us, take us a
little bit into that area
172
00:07:28,290 --> 00:07:29,880
of launching in rare diseases.
173
00:07:29,880 --> 00:07:31,650
- It's a great question.
174
00:07:31,650 --> 00:07:35,370
I think preparing a
launch in rare diseases is
175
00:07:35,370 --> 00:07:38,580
so much more complex,
176
00:07:38,580 --> 00:07:41,880
but oobviously a very interesting
exercise to do so
177
00:07:41,880 --> 00:07:43,800
with all respect, but
if we launch a product
178
00:07:43,800 --> 00:07:45,330
where we already have the expertise,
179
00:07:45,330 --> 00:07:47,700
you kind of know what you need to do.
180
00:07:47,700 --> 00:07:49,680
You have a kind of a road book for that.
181
00:07:49,680 --> 00:07:52,830
For rare diseases, it's
always exploring a little bit
182
00:07:52,830 --> 00:07:54,660
because you don't know the market.
183
00:07:54,660 --> 00:07:57,330
You don't know who the stakeholders are.
184
00:07:57,330 --> 00:07:59,760
You don't know always that
much about this disease.
185
00:07:59,760 --> 00:08:02,160
So, also that is a discovery.
186
00:08:02,160 --> 00:08:03,930
Also, you don't know really
187
00:08:03,930 --> 00:08:07,170
how the patients live with
that particular disease.
188
00:08:07,170 --> 00:08:08,970
So, all these aspects,
189
00:08:08,970 --> 00:08:12,750
before you start editing,
you need to map out.
190
00:08:12,750 --> 00:08:16,170
Again, that's why I'm saying
it's really a cross-functional
191
00:08:16,170 --> 00:08:19,620
work to prepare that kind of launch.
192
00:08:19,620 --> 00:08:21,090
Really, from a commercial point of view,
193
00:08:21,090 --> 00:08:24,480
we try to gather all that information
194
00:08:24,480 --> 00:08:28,233
and then see what's the
best plan moving forward,
195
00:08:29,430 --> 00:08:31,830
touching upon a few aspects of that,
196
00:08:31,830 --> 00:08:34,710
targeting a segmentation
exercise, for example, how-
197
00:08:34,710 --> 00:08:36,120
- Yeah.
- Who are the physicians
198
00:08:36,120 --> 00:08:38,610
or stakeholders you're going to target
199
00:08:38,610 --> 00:08:40,680
is a difficult exercise.
200
00:08:40,680 --> 00:08:43,860
So, of course, there is
market research you can do.
201
00:08:43,860 --> 00:08:46,650
You have your medical
team that is out there
202
00:08:46,650 --> 00:08:49,350
and gathering all these insights.
203
00:08:49,350 --> 00:08:52,560
We lately have a lot
of
information coming out
204
00:08:52,560 --> 00:08:53,790
of Veeva Link.
205
00:08:53,790 --> 00:08:56,490
So for us, Veeva Link is a
super interesting platform
206
00:08:56,490 --> 00:08:59,340
where we can, by searching
all of these buzzwords related
207
00:08:59,340 --> 00:09:00,600
to the rare diseases, find a lot
208
00:09:00,600 --> 00:09:03,420
of information about the key stakeholders.
209
00:09:03,420 --> 00:09:05,970
So, that helps us in
defining that targeting
210
00:09:05,970 --> 00:09:07,680
and segmentation exercise.
211
00:09:07,680 --> 00:09:09,030
That's one aspect.
212
00:09:09,030 --> 00:09:11,730
Secondly, we also have
a discussion on, yeah,
213
00:09:11,730 --> 00:09:14,070
which channels are we going to activate-
214
00:09:14,070 --> 00:09:15,420
- Yeah.
- To reach out
215
00:09:15,420 --> 00:09:19,080
to our customers and in rare diseases,
216
00:09:19,080 --> 00:09:20,370
yeah, you need to explore.
217
00:09:20,370 --> 00:09:23,070
So, as fast as we can,
we're going to discuss
218
00:09:23,070 --> 00:09:24,300
with the key stakeholders
219
00:09:24,300 --> 00:09:25,950
and ask them the honest question,
220
00:09:25,950 --> 00:09:26,790
what's the preferred channel?
221
00:09:26,790 --> 00:09:28,740
Do you want to meet a lot face to face?
222
00:09:28,740 --> 00:09:31,143
Do you want to be invited
to a lot of events?
223
00:09:32,652 --> 00:09:35,430
We wanna receive emails,
these kind of things.
224
00:09:35,430 --> 00:09:39,330
So, yeah, it's a little
bit a mix of that all.
225
00:09:39,330 --> 00:09:40,580
- And what would you say,
226
00:09:41,520 --> 00:09:44,040
what is more challenging versus
what is less challenging?
227
00:09:44,040 --> 00:09:46,500
So, where do you spend most of your time
228
00:09:46,500 --> 00:09:50,430
or energy in terms of that
preparation for the launch?
229
00:09:50,430 --> 00:09:52,650
- Maybe the most, and I
think the collaboration
230
00:09:52,650 --> 00:09:55,740
with marketing, once we have
enabled all of this channel
231
00:09:55,740 --> 00:09:58,380
is yeah, building that customer journey
232
00:09:58,380 --> 00:10:00,390
and adding to that customer journey,
233
00:10:00,390 --> 00:10:02,580
what are the perfect key messages?
234
00:10:02,580 --> 00:10:06,120
What is the perfect topics of discussion?
235
00:10:06,120 --> 00:10:08,880
Can we as a company
really make a difference
236
00:10:08,880 --> 00:10:10,350
for the patients?
237
00:10:10,350 --> 00:10:13,200
So, to really be really precise on that,
238
00:10:13,200 --> 00:10:15,723
defining that is maybe
the most challenging one.
239
00:10:17,070 --> 00:10:20,610
I think the most easy one is things that
240
00:10:20,610 --> 00:10:23,640
are related to what we do
with other launches as well.
241
00:10:23,640 --> 00:10:27,090
So, that's, I think we have
a great team at advance.
242
00:10:27,090 --> 00:10:29,310
So we, I mean, it's maybe arrogant to say,
243
00:10:29,310 --> 00:10:31,647
but I think we know what to do there.
244
00:10:31,647 --> 00:10:33,930
So, that's, yeah, all the
other aspects of the launch,
245
00:10:33,930 --> 00:10:36,630
I think we have quite under control.
246
00:10:36,630 --> 00:10:39,540
- You mentioned this
cross-functional nature, right,
247
00:10:39,540 --> 00:10:42,603
while preparing for a launch
in the next be executing it,
248
00:10:44,790 --> 00:10:48,150
how complicated is that for you?
249
00:10:48,150 --> 00:10:50,820
We always hear a lot from the industry,
250
00:10:50,820 --> 00:10:54,570
there are silos, people working in silos
251
00:10:54,570 --> 00:10:56,430
and not collaborating.
252
00:10:56,430 --> 00:10:57,930
How are you doing this at ADVANZ PHARMA
253
00:10:57,930 --> 00:11:00,120
and what's your secret recipe?
254
00:11:00,120 --> 00:11:02,430
- Yeah, it's maybe one of the reasons why
255
00:11:02,430 --> 00:11:04,410
I'm really happy to work at ADVANZ PHARMA
256
00:11:04,410 --> 00:11:06,153
is we have a lean structure.
257
00:11:09,150 --> 00:11:11,160
There were almost no silos, I would say.
258
00:11:11,160 --> 00:11:13,710
- Okay.
- So, it's always easy
259
00:11:13,710 --> 00:11:15,420
to go to all the departments.
260
00:11:15,420 --> 00:11:18,630
Also, horizontally, there
is almost no hierarchy.
261
00:11:18,630 --> 00:11:22,200
So, you can jump at any
moment to any person.
262
00:11:22,200 --> 00:11:23,190
You can sit together.
263
00:11:23,190 --> 00:11:26,670
So, it's very easy to
communicate with that
264
00:11:26,670 --> 00:11:28,920
and even more, there are a lot of forms,
265
00:11:28,920 --> 00:11:32,280
cross-functional forms We
organize to prepare, for example,
266
00:11:32,280 --> 00:11:35,520
launches where we all
discuss this kind of thing.
267
00:11:35,520 --> 00:11:39,960
So, no, it's great to
be at ADVANZ for that.
268
00:11:39,960 --> 00:11:43,200
- And assuming that medical
plays a key role in this,
269
00:11:43,200 --> 00:11:44,033
right?
- Yeah.
270
00:11:44,033 --> 00:11:46,773
- Now, you're coming from a
commercial side of things.
271
00:11:47,820 --> 00:11:51,360
Take us a little bit into the
collaboration with medical.
272
00:11:51,360 --> 00:11:53,580
How do you perceive that
also from a commercial side
273
00:11:53,580 --> 00:11:57,020
and what may be some tricks-
- Yeah.
274
00:11:57,020 --> 00:11:59,400
- Of how to best collaborate with medical
275
00:11:59,400 --> 00:12:00,810
in such a launch setting?
276
00:12:00,810 --> 00:12:04,080
- Yeah. First of all,
I've never seen before,
277
00:12:04,080 --> 00:12:05,970
and I think I can speak from experience
278
00:12:05,970 --> 00:12:06,960
in more than 20 years,
279
00:12:06,960 --> 00:12:09,750
such a close collaboration
between medical and commercial.
280
00:12:09,750 --> 00:12:13,260
And the fact that there is
also a medical excellence
281
00:12:13,260 --> 00:12:16,500
responsible person in ADVANZ really helps
282
00:12:16,500 --> 00:12:18,630
to have that conversation.
283
00:12:18,630 --> 00:12:21,600
So, coming back specifically
on launches,
284
00:12:21,600 --> 00:12:24,100
it's maybe the period where
we work mostly together.
285
00:12:24,100 --> 00:12:25,290
- Yeah.
- Just to make sure
286
00:12:25,290 --> 00:12:27,570
we are doing the right thing.
287
00:12:27,570 --> 00:12:29,760
They play a crucial role pre-launch.
288
00:12:29,760 --> 00:12:33,090
They gather so much insight,
so much information,
289
00:12:33,090 --> 00:12:34,983
organizing so many events already,
290
00:12:35,880 --> 00:12:37,320
and they share that information.
291
00:12:37,320 --> 00:12:39,990
So, what I've seen before
is that, yeah, due to,
292
00:12:39,990 --> 00:12:43,350
and obviously often there are
legal or compliance issues,
293
00:12:43,350 --> 00:12:44,580
but there's a lot you can share.
294
00:12:44,580 --> 00:12:46,980
And often there is a
strict line between both.
295
00:12:46,980 --> 00:12:49,080
And that's not what I'm seeing in advance.
296
00:12:49,080 --> 00:12:51,750
Luckily, there is a good,
healthy way of sharing
297
00:12:51,750 --> 00:12:54,450
that information, and that really helps us
298
00:12:54,450 --> 00:12:56,190
defining the strategy so much better.
299
00:12:56,190 --> 00:13:00,030
Yeah. And to be really much
more ready prior to our launch.
300
00:13:00,030 --> 00:13:02,340
- Now, along that process
that you're working through
301
00:13:02,340 --> 00:13:05,280
with the colleagues,
what isn't working well
302
00:13:05,280 --> 00:13:08,160
or what can be done better, right,
303
00:13:08,160 --> 00:13:09,900
in preparing for such a launch?
304
00:13:09,900 --> 00:13:11,670
What are some of the ingredients
305
00:13:11,670 --> 00:13:13,290
that you think may still be missing
306
00:13:13,290 --> 00:13:15,060
or that you need to be working on?
307
00:13:15,060 --> 00:13:18,930
- I think, it's sometimes
lack of resources,
308
00:13:18,930 --> 00:13:22,050
you may say, because it's,
I'm talking about launches,
309
00:13:22,050 --> 00:13:24,123
and again, we have a few,
310
00:13:25,050 --> 00:13:27,930
but don't forget also
the ongoing business.
311
00:13:27,930 --> 00:13:30,660
And for me, that's sometimes
maybe the most challenging one.
312
00:13:30,660 --> 00:13:32,160
You also have an ongoing business.
313
00:13:32,160 --> 00:13:34,560
So, your field teams are, prior to launch,
314
00:13:34,560 --> 00:13:37,560
already promoting other drugs as well.
315
00:13:37,560 --> 00:13:40,500
And you need to keep on
focusing on that as well.
316
00:13:40,500 --> 00:13:44,070
It's not that you are promoting
a drug a few years already,
317
00:13:44,070 --> 00:13:45,600
that you don't need to invest in that.
318
00:13:45,600 --> 00:13:48,780
There are also always new
channels you need to activate,
319
00:13:48,780 --> 00:13:52,170
new tactics you want to bring in place.
320
00:13:52,170 --> 00:13:56,340
So, seeking the balance between both is
321
00:13:56,340 --> 00:13:58,380
to be fully focused and doing
the right thing for a launch.
322
00:13:58,380 --> 00:14:01,590
But also, yeah, giving enough attention
323
00:14:01,590 --> 00:14:03,720
to the ongoing business is for me,
324
00:14:03,720 --> 00:14:06,060
sometimes the most challenging one,
325
00:14:06,060 --> 00:14:09,030
specifically looking at
my own bucket of work,
326
00:14:09,030 --> 00:14:14,030
CRM and digital, yeah, that's
a very demanding thing.
327
00:14:14,790 --> 00:14:17,880
People reach out to you
always for new updates,
328
00:14:17,880 --> 00:14:19,120
for new requirements.
329
00:14:19,120 --> 00:14:20,160
- Yeah.
- And in the meantime,
330
00:14:20,160 --> 00:14:23,040
you're working on preparing
everything for launch or, yeah.
331
00:14:23,040 --> 00:14:24,630
- Oh, that's a very interesting aspect.
332
00:14:24,630 --> 00:14:27,300
And now looking at what you're going to do
333
00:14:27,300 --> 00:14:28,133
in the next years, right,
334
00:14:28,133 --> 00:14:29,790
there's more and more products going
335
00:14:29,790 --> 00:14:31,410
to be on market actually.
336
00:14:31,410 --> 00:14:32,850
How do you make that trade off?
337
00:14:32,850 --> 00:14:36,720
How do you actually think about that?
338
00:14:36,720 --> 00:14:37,980
How do you prioritize?
339
00:14:37,980 --> 00:14:40,263
- Yeah. Yeah.
340
00:14:41,250 --> 00:14:43,050
It's an ongoing discussion,
341
00:14:43,050 --> 00:14:45,723
an ongoing prioritization exercise.
342
00:14:46,710 --> 00:14:49,150
The first step we do
always at the global level
343
00:14:50,070 --> 00:14:52,680
to make that exercise.
344
00:14:52,680 --> 00:14:53,910
But I must say we also,
345
00:14:53,910 --> 00:14:57,330
it's something we openly
discuss with the countries.
346
00:14:57,330 --> 00:15:01,740
You see, often in companies,
a top down structure
347
00:15:01,740 --> 00:15:02,850
where you take decisions
348
00:15:02,850 --> 00:15:05,073
and countries just need to implement.
349
00:15:05,970 --> 00:15:07,800
I think at the global level, again,
350
00:15:07,800 --> 00:15:12,180
together with medical,
we take certain decisions
351
00:15:12,180 --> 00:15:15,540
or we, I would say, we
give certain guidance
352
00:15:15,540 --> 00:15:16,920
and then we discuss with the countries
353
00:15:16,920 --> 00:15:17,820
and they have the right
354
00:15:17,820 --> 00:15:20,430
and there is the opportunity to push back.
355
00:15:20,430 --> 00:15:23,160
And then we can have a second discussion,
356
00:15:23,160 --> 00:15:25,890
but before we take a certain decision,
357
00:15:25,890 --> 00:15:28,200
it's based on, yeah, lot of interactions.
358
00:15:28,200 --> 00:15:30,450
And then we have the buy-in
from different departments,
359
00:15:30,450 --> 00:15:31,560
but also from the countries.
360
00:15:31,560 --> 00:15:34,050
I think that is really crucial.
361
00:15:34,050 --> 00:15:35,650
Don't forget that ADVANZ PHARMA,
362
00:15:36,600 --> 00:15:39,550
I think we have a commercial
presence in 20 countries.
363
00:15:39,550 --> 00:15:40,890
- Yeah.
- And they each
364
00:15:40,890 --> 00:15:41,820
have a different
approach.
365
00:15:41,820 --> 00:15:43,320
Not every country is the same, of course,
366
00:15:43,320 --> 00:15:46,440
so taking decision at a global level,
367
00:15:46,440 --> 00:15:48,990
yeah, you just need to make
sure that it's feasible
368
00:15:48,990 --> 00:15:50,940
and it's practical,
369
00:15:50,940 --> 00:15:53,103
applicable in all of the countries, yeah.
370
00:15:54,000 --> 00:15:55,590
- Now, you've been mentioning
371
00:15:55,590 --> 00:16:00,330
that data plays a crucial role
in preparing for a launch.
372
00:16:00,330 --> 00:16:01,740
And at ADVANZ PHARMA,
373
00:16:01,740 --> 00:16:03,510
I think you're probably
at the cutting edge
374
00:16:03,510 --> 00:16:06,660
of using reference data,
but also deep data.
375
00:16:06,660 --> 00:16:09,300
You mentioned KOL
specific intelligence data
376
00:16:09,300 --> 00:16:11,607
- Yep.
- And using and preparing
377
00:16:11,607 --> 00:16:12,840
for a launch.
378
00:16:12,840 --> 00:16:14,580
Can you give a couple of examples
379
00:16:14,580 --> 00:16:15,720
of how you're actually doing that
380
00:16:15,720 --> 00:16:18,870
and how it is helping you with launching?
381
00:16:18,870 --> 00:16:19,800
- Yeah.
382
00:16:19,800 --> 00:16:23,130
So, data is obviously crucial
383
00:16:23,130 --> 00:16:27,210
to prepare a launch, physician data,
384
00:16:27,210 --> 00:16:29,580
but there's also, yeah, the markets,
385
00:16:29,580 --> 00:16:32,820
the disease area is you want
to collect a lot of data,
386
00:16:32,820 --> 00:16:35,850
patient population, the patient journeys,
387
00:16:35,850 --> 00:16:38,040
all of that data is very crucial
388
00:16:38,040 --> 00:16:40,203
to define your strategy.
389
00:16:42,180 --> 00:16:47,180
Once you are in the period of launching,
390
00:16:47,310 --> 00:16:51,720
you set your KPIs that you defined based
391
00:16:51,720 --> 00:16:53,970
on the strategy and your tactics.
392
00:16:53,970 --> 00:16:55,590
I think it's crucial as from the beginning
393
00:16:55,590 --> 00:16:57,390
to also measure those
394
00:16:57,390 --> 00:16:59,520
because it gives you
a direction, a flavor.
395
00:16:59,520 --> 00:17:00,630
Did you do the right thing?
396
00:17:00,630 --> 00:17:01,800
Did you set the right KPIs?
397
00:17:01,800 --> 00:17:03,270
Did you take the right decision?
398
00:17:03,270 --> 00:17:06,210
So, from early stage,
data plays a crucial role
399
00:17:06,210 --> 00:17:07,170
and also measuring it.
400
00:17:07,170 --> 00:17:08,970
So, we are very lucky also
401
00:17:08,970 --> 00:17:10,140
in our commercial excellence team,
402
00:17:10,140 --> 00:17:13,020
we have two dedicated people
on reporting and analytics.
403
00:17:13,020 --> 00:17:14,670
So, all the data that is coming in
404
00:17:14,670 --> 00:17:16,830
is being a little bit handled by them.
405
00:17:16,830 --> 00:17:19,620
And I think they're doing
a very, very good job.
406
00:17:19,620 --> 00:17:23,010
Again, also analyzing data
from the ongoing business,
407
00:17:23,010 --> 00:17:24,960
but then specifically during a launch
408
00:17:24,960 --> 00:17:28,260
and prior to a launch to, yeah,
409
00:17:28,260 --> 00:17:29,970
do magical things with the data
410
00:17:29,970 --> 00:17:31,950
and give us the right insights, yeah.
411
00:17:31,950 --> 00:17:34,500
- And how you applying the data?
412
00:17:34,500 --> 00:17:37,020
So, you mentioned segmentation
413
00:17:37,020 --> 00:17:39,060
and targeting, for example,
I'm assuming that's one
414
00:17:39,060 --> 00:17:41,220
of the core applications before launch.
415
00:17:41,220 --> 00:17:42,900
- Yeah.
- How does it help you
416
00:17:42,900 --> 00:17:46,110
to actually prepare for
a successful launch?
417
00:17:46,110 --> 00:17:49,380
- Yeah, so targeting
segmentation exercise is really
418
00:17:49,380 --> 00:17:52,413
important to set certain targets,
419
00:17:53,250 --> 00:17:58,023
so to define your product
planning and your call planning.
420
00:17:58,890 --> 00:18:00,600
But as I was saying, it's crucial
421
00:18:00,600 --> 00:18:02,910
to measure as from the beginning.
422
00:18:02,910 --> 00:18:04,260
I mean, you do that exercise based
423
00:18:04,260 --> 00:18:07,230
on all the data you had before,
but once you're out there,
424
00:18:07,230 --> 00:18:10,170
if I may say in the field, you receive
425
00:18:10,170 --> 00:18:13,020
so many other inputs
and so many other data,
426
00:18:13,020 --> 00:18:15,300
and you need to have that
flexibility also change that.
427
00:18:15,300 --> 00:18:18,780
So, in CRM, we can
easily adapt our targets
428
00:18:18,780 --> 00:18:22,773
and segmentation, adoption
letters, et cetera.
429
00:18:23,790 --> 00:18:27,840
And we want to incorporate a
lot of these measurement points
430
00:18:27,840 --> 00:18:29,400
where we do a kind of a status check,
431
00:18:29,400 --> 00:18:31,080
are we still doing the right thing?
432
00:18:31,080 --> 00:18:33,450
Do we need to make certain adaptations?
433
00:18:33,450 --> 00:18:36,840
So, yeah, you need to be
flexible on that as well.
434
00:18:36,840 --> 00:18:40,350
- Okay, data is probably one
435
00:18:40,350 --> 00:18:42,870
of the most discussed
topics in our industry.
436
00:18:42,870 --> 00:18:43,703
Right?
- Yeah.
437
00:18:43,703 --> 00:18:44,640
- And for very good reasons.
438
00:18:44,640 --> 00:18:46,920
And there is a lot of data out there.
439
00:18:46,920 --> 00:18:47,753
- Yeah, yeah.
- Healthcare data
440
00:18:47,753 --> 00:18:49,440
in general is exploding.
- Yeah.
441
00:18:49,440 --> 00:18:51,780
- So, it sometimes can be difficult
442
00:18:51,780 --> 00:18:56,400
to choose which data actually
to use and which not.
443
00:18:56,400 --> 00:18:59,250
So, where to look and
what to ask the data.
444
00:18:59,250 --> 00:19:02,000
How do you think maybe a bit
more generally about data?
445
00:19:03,750 --> 00:19:06,270
What would you wish for
446
00:19:06,270 --> 00:19:08,940
if you had access to certain types of data
447
00:19:08,940 --> 00:19:11,370
or how
will data become
even more important
448
00:19:11,370 --> 00:19:12,970
for you or more useful?
- Yeah.
449
00:19:13,920 --> 00:19:15,420
What is maybe the most challenging today?
450
00:19:15,420 --> 00:19:17,460
What would would be really
helpful then as well
451
00:19:17,460 --> 00:19:19,950
is you have external sources of data,
452
00:19:19,950 --> 00:19:23,910
data you gather to
vendors, to market research
453
00:19:23,910 --> 00:19:26,970
that other people did to other platform.
454
00:19:26,970 --> 00:19:29,670
And then you have the data
you collect internally-
455
00:19:29,670 --> 00:19:30,990
- Yeah.
- And that you have.
456
00:19:30,990 --> 00:19:34,110
I think if there would
be a way to match those
457
00:19:34,110 --> 00:19:35,850
and to do analysis and to mix,
458
00:19:35,850 --> 00:19:37,020
obviously, we are working on that.
459
00:19:37,020 --> 00:19:40,170
As I said, we have two
persons responsible for that,
460
00:19:40,170 --> 00:19:43,260
but that's challenging
to combine those myth.
461
00:19:43,260 --> 00:19:45,480
I think maybe in a very near future,
462
00:19:45,480 --> 00:19:46,620
or maybe it's already ongoing,
463
00:19:46,620 --> 00:19:51,570
artificial intelligence
can help us analyzing
464
00:19:51,570 --> 00:19:54,000
both sources of data externally, internal,
465
00:19:54,000 --> 00:19:56,430
and, yeah, helps us making
the right conclusions
466
00:19:56,430 --> 00:19:58,140
and giving us the right insights.
467
00:19:58,140 --> 00:19:59,370
So, yeah.
468
00:19:59,370 --> 00:20:00,690
- Almost like what you're saying,
469
00:20:00,690 --> 00:20:03,810
almost like an industry taxonomy
470
00:20:03,810 --> 00:20:05,670
that lets data fit together.
471
00:20:05,670 --> 00:20:06,930
- Absolutely. Absolutely.
472
00:20:06,930 --> 00:20:09,060
And as you said, there is
so much sources of data
473
00:20:09,060 --> 00:20:12,090
at some point you also
need to cut it off, I mean,
474
00:20:12,090 --> 00:20:15,720
and take a decision based
on the data we have today.
475
00:20:15,720 --> 00:20:18,150
We take certain decisions and
we go through certain tactics
476
00:20:18,150 --> 00:20:20,100
and a certain strategy because, yeah,
477
00:20:20,100 --> 00:20:22,710
sometimes it can be overwhelming, yeah.
478
00:20:22,710 --> 00:20:25,570
But I think the most important
source of data remains
479
00:20:26,490 --> 00:20:28,260
the reactions of your stakeholders
480
00:20:28,260 --> 00:20:29,490
when you engage with them.
481
00:20:29,490 --> 00:20:33,210
I think that remains a super
crucial piece of information
482
00:20:33,210 --> 00:20:34,980
because they have the
content with the patient.
483
00:20:34,980 --> 00:20:38,370
They know exactly what is
working, what is needed.
484
00:20:38,370 --> 00:20:41,520
So, maybe that's the most
important lesson for us,
485
00:20:41,520 --> 00:20:42,960
based on all that information,
486
00:20:42,960 --> 00:20:44,250
if you don't know exactly what
487
00:20:44,250 --> 00:20:47,730
or which direction to go at,
listen to the physicians.
488
00:20:47,730 --> 00:20:50,820
And that feedback is often
coming from the field teams,
489
00:20:50,820 --> 00:20:53,163
MSLs and KAMs, yeah.
490
00:20:54,540 --> 00:20:56,040
- And maybe last question on this,
491
00:20:56,040 --> 00:20:57,930
because you're saying
a lot of internal data
492
00:20:57,930 --> 00:20:59,680
that is also coming from the field.
493
00:21:01,470 --> 00:21:06,300
Any thoughts on how to
improve even the quality more
494
00:21:06,300 --> 00:21:07,410
that is coming from the field?
495
00:21:07,410 --> 00:21:09,630
Because a lot of discussion
is usually also going on.
496
00:21:09,630 --> 00:21:11,130
- Yeah.
- What are we capturing?
497
00:21:11,130 --> 00:21:12,270
What are we not capturing right?
498
00:21:12,270 --> 00:21:14,040
And what insights can we draw from that?
499
00:21:14,040 --> 00:21:16,410
- Yeah, the question is
500
00:21:16,410 --> 00:21:18,750
what are you capturing and
where do you capture it?
501
00:21:18,750 --> 00:21:22,050
Often that crucial information
coming from the field,
502
00:21:22,050 --> 00:21:24,427
obviously we have our CRM for that.
503
00:21:24,427 --> 00:21:25,530
- Yeah.
504
00:21:25,530 --> 00:21:28,140
- There used to be a time
that everything was collected
505
00:21:28,140 --> 00:21:30,480
on pieces of paper, in Excel sheets,
506
00:21:30,480 --> 00:21:33,630
and that can be also
dangerous because, yeah,
507
00:21:33,630 --> 00:21:36,930
there is also a certain
way to collect data
508
00:21:36,930 --> 00:21:40,050
and cannot be distributed and everything.
509
00:21:40,050 --> 00:21:44,310
So, I think we've done a good
job in setting up the CRM
510
00:21:44,310 --> 00:21:47,310
to capture the crucial data
in a very compliant way,
511
00:21:47,310 --> 00:21:50,433
but also that it's
afterwards easy to analyze.
512
00:21:51,390 --> 00:21:54,660
To give you two clear, tangible examples,
513
00:21:54,660 --> 00:21:57,570
we have a pre-launch module now in CRM.
514
00:21:57,570 --> 00:22:00,960
So, when MSLs are in the fields engaging
515
00:22:00,960 --> 00:22:03,300
with customers prior to a launch,
516
00:22:03,300 --> 00:22:04,860
there are certain pieces of information
517
00:22:04,860 --> 00:22:08,010
that we store in that
pre-launch module in CRM,
518
00:22:08,010 --> 00:22:11,130
like in a certain important account
519
00:22:11,130 --> 00:22:14,580
or center of excellence, who
is the leading physician?
520
00:22:14,580 --> 00:22:18,270
Who are the prescribers,
who is the influencer,
521
00:22:18,270 --> 00:22:21,900
who is the main pharmacist,
and these kinds of things.
522
00:22:21,900 --> 00:22:22,733
And that's crucial.
523
00:22:22,733 --> 00:22:24,480
You do it in a very compliant way,
524
00:22:24,480 --> 00:22:28,140
and then afterwards
it's very useful to use.
525
00:22:28,140 --> 00:22:32,160
But also the KAMs are using in
a very compliant way the CRM-
526
00:22:32,160 --> 00:22:32,993
- Yeah.
527
00:22:32,993 -->
00:22:36,480
- In a very optimal way
to gather all information
528
00:22:36,480 --> 00:22:40,980
like enablers, barriers, adoption ladders,
529
00:22:40,980 --> 00:22:44,070
which we then try to fit
in a customer journey.
530
00:22:44,070 --> 00:22:46,740
- And I'm also hearing quite
cross-functional use then
531
00:22:46,740 --> 00:22:48,120
- Yes.
- Of a core system
532
00:22:48,120 --> 00:22:49,110
that brings everything together.
533
00:22:49,110 --> 00:22:49,943
- Yeah. Absolutely.
534
00:22:49,943 --> 00:22:50,850
I think that's crucial.
- Yeah.
535
00:22:50,850 --> 00:22:53,970
- Because otherwise, you ask a lot effort
536
00:22:53,970 --> 00:22:56,670
from the field teams to capture that data,
537
00:22:56,670 --> 00:22:59,490
but if then there is no
use of it afterwards,
538
00:22:59,490 --> 00:23:01,470
it's really lost the effort, yeah.
539
00:23:01,470 --> 00:23:02,310
- Yeah. Yeah.
540
00:23:02,310 --> 00:23:05,940
Now, and you were talking
about the field teams
541
00:23:05,940 --> 00:23:08,763
and as they're interacting with customers,
542
00:23:09,960 --> 00:23:11,880
there is other...
543
00:23:11,880 --> 00:23:13,830
And customers in your case actually can be
544
00:23:13,830 --> 00:23:14,950
different groups of people, right?
545
00:23:14,950 --> 00:23:15,990
Yeah.
- So, you've got,
546
00:23:15,990 --> 00:23:17,220
of course, on the one hand side,
547
00:23:17,220 --> 00:23:19,470
the physicians who are treating patients,
548
00:23:19,470 --> 00:23:21,600
but especially in rare diseases,
549
00:23:21,600 --> 00:23:22,800
there's more around this, right?
550
00:23:22,800 --> 00:23:24,623
There's nurses who are fairly important-
551
00:23:24,623 --> 00:23:25,860
- Yes.
- In this context.
552
00:23:25,860 --> 00:23:27,180
- Yeah.
- There is also caregivers
553
00:23:27,180 --> 00:23:28,350
- Yes.
554
00:23:28,350 --> 00:23:30,810
- And private caregivers
who are important.
555
00:23:30,810 --> 00:23:34,800
- Yeah.
- Now, how do you engage,
556
00:23:34,800 --> 00:23:37,590
or how do you plan for
this type of complexity
557
00:23:37,590 --> 00:23:40,290
in the healthcare professional
space on your end?
558
00:23:40,290 --> 00:23:42,150
- Yeah, so, in my end,
559
00:23:42,150 --> 00:23:44,880
from a CRM point of
view, it's super crucial.
560
00:23:44,880 --> 00:23:48,000
As you mentioned, there are
different types of stakeholders,
561
00:23:48,000 --> 00:23:50,160
and you have done the
20 different countries
562
00:23:50,160 --> 00:23:53,070
I just spoke about where
there is a different approach.
563
00:23:53,070 --> 00:23:54,780
Some of them are more tender driven,
564
00:23:54,780 --> 00:23:57,060
otherwise it's retail, pharmacy sales,
565
00:23:57,060 --> 00:23:58,710
just saying something.
566
00:23:58,710 --> 00:24:01,440
So, yeah, you have different
types of stakeholders
567
00:24:01,440 --> 00:24:03,450
and different types of models,
568
00:24:03,450 --> 00:24:05,520
commercial models in a country.
569
00:24:05,520 --> 00:24:07,260
I think from a CRM point of view,
570
00:24:07,260 --> 00:24:11,610
you need to set it up in the
right way for those people.
571
00:24:11,610 --> 00:24:14,280
We had in the beginning a
few struggles in some markets
572
00:24:14,280 --> 00:24:16,470
where other types of
stakeholders, if I may,
573
00:24:16,470 --> 00:24:21,060
other type of stakeholders
than HCPs were more important.
574
00:24:21,060 --> 00:24:21,893
And then in the beginning,
575
00:24:21,893 --> 00:24:23,550
we had a little bit more struggles in CRM
576
00:24:23,550 --> 00:24:25,530
to have the database behind.
577
00:24:25,530 --> 00:24:28,440
Right, I think also,
again, great partnership
578
00:24:28,440 --> 00:24:31,320
with Veeva to have that in place,
579
00:24:31,320 --> 00:24:33,180
talking specifically on payers
580
00:24:33,180 --> 00:24:35,043
and nurses to have into the system.
581
00:24:36,060 --> 00:24:38,430
I think the database
we have is quite good.
582
00:24:38,430 --> 00:24:40,650
And if we are in situation that some
583
00:24:40,650 --> 00:24:43,260
of the customers are
missing, often different type
584
00:24:43,260 --> 00:24:45,060
of stakeholders, we create them now
585
00:24:45,060 --> 00:24:49,500
as great record in a sort
of advanced own database.
586
00:24:49,500 --> 00:24:50,520
Because it's important
587
00:24:50,520 --> 00:24:53,070
those people interact
with this type of stake-.
588
00:24:53,070 --> 00:24:54,210
The field teams are interacting
589
00:24:54,210 --> 00:24:56,070
with these different type of stakeholders.
590
00:24:56,070 --> 00:24:57,540
They need to capture that in the same way
591
00:24:57,540 --> 00:25:00,900
as we interact with physicians.
592
00:25:00,900 --> 00:25:03,510
- Okay. So, important to capture it all.
593
00:25:03,510 --> 00:25:04,343
- Yes.
- But enable
594
00:25:04,343 --> 00:25:05,840
also your field teams to-
- Yeah.
595
00:25:06,750 --> 00:25:09,840
- To be able to use technology
with other customers.
596
00:25:09,840 --> 00:25:10,770
- Exactly. Exactly.
597
00:25:10,770 --> 00:25:11,603
That's super important.
598
00:25:11,603 --> 00:25:12,630
Capturing data is one thing,
599
00:25:12,630 --> 00:25:14,100
but then you just need to make sure
600
00:25:14,100 --> 00:25:18,030
that all the channels you
enable in your multi-channel
601
00:25:18,030 --> 00:25:20,730
or omni-channel approach, you enable them
602
00:25:20,730 --> 00:25:22,227
for all types of stakeholders.
603
00:25:22,227 --> 00:25:23,197
- Yeah.
- That's, yeah.
604
00:25:23,197 --> 00:25:25,050
So that's crucial.
605
00:25:25,050 --> 00:25:26,400
- We are on the topic of customers.
606
00:25:26,400 --> 00:25:28,620
I want to stay there just
for a little bit longer.
607
00:25:28,620 --> 00:25:31,110
And connected to something
you said earlier,
608
00:25:31,110 --> 00:25:35,460
the space is also becoming
more competitive, right?
609
00:25:35,460 --> 00:25:37,230
So, you're launching in rare diseases,
610
00:25:37,230 --> 00:25:39,780
but
also rare disease is
a very strong focus area-
611
00:25:39,780 --> 00:25:41,100
- Yeah.
- For many other companies.
612
00:25:41,100 --> 00:25:43,020
So, there is a certain
level of competition,
613
00:25:43,020 --> 00:25:45,363
you're not acting in a vacuum.
- Yeah.
614
00:25:46,320 --> 00:25:49,050
- Now, within the realms of
what you're obviously happy
615
00:25:49,050 --> 00:25:51,540
to share, but customer experience can be
616
00:25:51,540 --> 00:25:56,070
one very crucial differentiator
also versus competition.
617
00:25:56,070 --> 00:25:58,830
How do you think about
the customer experience
618
00:25:58,830 --> 00:26:01,590
that you're delivering and
what are you trying to achieve
619
00:26:01,590 --> 00:26:03,396
or how do you want to make it better?
620
00:26:03,396 --> 00:26:05,280
- Yeah, yeah. Great question.
621
00:26:05,280 --> 00:26:07,800
I don't want to talk too
much about competition.
622
00:26:07,800 --> 00:26:10,380
I think it's always good
to focus on yourself,
623
00:26:10,380 --> 00:26:14,250
but obviously, yeah, you
realize it's important.
624
00:26:14,250 --> 00:26:17,830
I think that optimal customer experience
625
00:26:19,020 --> 00:26:22,680
is again, based on the data you have
626
00:26:22,680 --> 00:26:25,143
and a certain tactic you put in place.
627
00:26:26,430 --> 00:26:29,280
At that point, when you start
engaging with physicians,
628
00:26:29,280 --> 00:26:32,643
I guess it's a simple thing
as just asking feedback.
629
00:26:34,230 --> 00:26:35,610
It just, afterwards,
630
00:26:35,610 --> 00:26:37,830
after a discussion, you
can ask honestly, feedback.
631
00:26:37,830 --> 00:26:40,890
Is this the topic you wanted to discuss?
632
00:26:40,890 --> 00:26:43,260
Is this the channel you like?
633
00:26:43,260 --> 00:26:44,280
Is there anything else?
634
00:26:44,280 --> 00:26:46,950
I think that open
communication is super crucial
635
00:26:46,950 --> 00:26:48,060
more than ever.
636
00:26:48,060 --> 00:26:50,070
So, we are talking a lot
about technology here,
637
00:26:50,070 --> 00:26:52,050
but I think it's also important.
638
00:26:52,050 --> 00:26:53,190
And we are doing that
639
00:26:53,190 --> 00:26:55,440
in our commercial excellence
department that as well,
640
00:26:55,440 --> 00:26:57,030
focusing a lot on training.
641
00:26:57,030 --> 00:26:59,550
I think it's super important
to keep on training
642
00:26:59,550 --> 00:27:01,570
and investment in your field team people
643
00:27:02,610 --> 00:27:05,220
and teaching them and learning
them that it's okay to have
644
00:27:05,220 --> 00:27:07,260
that kind of interactions as well,
645
00:27:07,260 --> 00:27:08,790
because customer experience, as you say,
646
00:27:08,790 --> 00:27:10,110
is the most important one
647
00:27:10,110 --> 00:27:12,960
and can make them a difference
again versus competition.
648
00:27:12,960 --> 00:27:15,120
So, we are realizing that.
649
00:27:15,120 --> 00:27:17,340
I don't think we're doing it
already in an optimal way,
650
00:27:17,340 --> 00:27:20,010
but yeah, we have a plan
moving forward to improve
651
00:27:20,010 --> 00:27:22,050
that even better, specifically now
652
00:27:22,050 --> 00:27:24,030
that we focus more on rare diseases
653
00:27:24,030 --> 00:27:27,540
and that customer experience
is super, super crucial, yeah.
654
00:27:27,540 --> 00:27:29,970
- And without going into
specifics, what are some
655
00:27:29,970 --> 00:27:33,030
of the core drivers for this experience
656
00:27:33,030 --> 00:27:34,200
that you want to work on?
657
00:27:34,200 --> 00:27:37,290
What are aspects that are in your focus
658
00:27:37,290 --> 00:27:38,430
or that are important to you?
659
00:27:38,430 --> 00:27:39,630
- Yeah.
660
00:27:39,630 --> 00:27:43,080
Yeah, because we are
speaking about rare diseases,
661
00:27:43,080 --> 00:27:45,870
there were a lot of unknown factors.
662
00:27:45,870 --> 00:27:48,300
As I told you already, for the
patients, for the physician,
663
00:27:48,300 --> 00:27:50,070
but also for us.
- Yeah.
664
00:27:50,070 --> 00:27:52,050
- So, you're trying to do the right thing.
665
00:27:52,050 --> 00:27:54,870
The physician is trying
to do the right thing,
666
00:27:54,870 --> 00:27:59,340
but I think that open
communication is crucial there
667
00:27:59,340 --> 00:28:02,190
more than ever because
yeah, there is, as I said,
668
00:28:02,190 --> 00:28:04,443
a lot of unknown factors there.
669
00:28:05,820 --> 00:28:09,180
I would say one of the examples is type
670
00:28:09,180 --> 00:28:11,460
of events you want to
organize as an organization.
671
00:28:11,460 --> 00:28:15,900
I think we often organize
big advocacy meetings
672
00:28:15,900 --> 00:28:20,200
or speaker meetings
maybe for rare diseases.
673
00:28:20,200 --> 00:28:21,180
- Yeah.
- You wanna do
674
00:28:21,180 --> 00:28:24,330
something completely
different and in a more, yeah,
675
00:28:24,330 --> 00:28:26,490
really smaller setting.
676
00:28:26,490 --> 00:28:29,250
Really want to have highly scientific,
677
00:28:29,250 --> 00:28:32,400
high value discussions at the lower scale.
678
00:28:32,400 --> 00:28:34,800
I'm just saying something,
but you need to have
679
00:28:34,800 --> 00:28:36,540
that conversation just, you know,
680
00:28:36,540 --> 00:28:38,850
to make sure you're doing the right thing.
681
00:28:38,850 --> 00:28:42,210
- So, we were talking
about customer experience,
682
00:28:42,210 --> 00:28:43,980
but also patient experience
ultimately, right.
683
00:28:43,980 --> 00:28:46,020
And that may start actually earlier-
684
00:28:46,020 --> 00:28:48,360
- Yeah.
- Than with the treatment,
685
00:28:48,360 --> 00:28:49,620
potentially in a clinical trial
686
00:28:49,620 --> 00:28:52,500
or on the way there,
diagnostics, et cetera.
687
00:28:52,500 --> 00:28:55,590
How are you thinking
about, kind of, that fact
688
00:28:55,590 --> 00:28:59,760
that experience stretches
is a journey basically,
689
00:28:59,760 --> 00:29:02,760
and what are your thoughts
on how
to optimize it maybe?
690
00:29:02,760 --> 00:29:03,610
- No, absolutely.
691
00:29:04,530 --> 00:29:06,360
Especially in rare diseases,
692
00:29:06,360 --> 00:29:10,170
and I'm not talking
now for ADVANZ as such.
693
00:29:10,170 --> 00:29:15,120
I think all the experiences
you have from clinical trials
694
00:29:15,120 --> 00:29:18,090
until the whole moment
695
00:29:18,090 --> 00:29:20,820
where you're actually
launching a new product
696
00:29:20,820 --> 00:29:22,170
are more than ever crucial.
697
00:29:23,517 --> 00:29:25,627
All of these aspects, you really want
698
00:29:25,627 --> 00:29:30,627
to measure and see what the
patient actually go through.
699
00:29:30,960 --> 00:29:32,970
What is the experience of the physicians?
700
00:29:32,970 --> 00:29:34,740
Often, it's more than one specialty
701
00:29:34,740 --> 00:29:35,700
in rare diseases.
- Yeah.
702
00:29:35,700 --> 00:29:38,040
- It's not that one specialty is focused
703
00:29:38,040 --> 00:29:39,600
on a specific rare disease.
704
00:29:39,600 --> 00:29:43,140
Often it's across specialty thing.
705
00:29:43,140 --> 00:29:48,140
So, all those experience are
super crucial in that, yeah.
706
00:29:50,340 --> 00:29:52,983
- And building on these experiences,
707
00:29:54,300 --> 00:29:57,390
how do you pick them up
potentially in your work, right?
708
00:29:57,390 --> 00:29:59,730
So, how do you work
with all this experience
709
00:29:59,730 --> 00:30:01,620
that has been gathered or also input
710
00:30:01,620 --> 00:30:05,340
that has happened before
you actually come into play?
711
00:30:05,340 --> 00:30:08,250
- Yeah, so specifically for rare diseases,
712
00:30:08,250 --> 00:30:11,970
you built a patient journey
from the moment it's diagnosed
713
00:30:11,970 --> 00:30:15,063
and all of the experiences
with the treatment as such.
714
00:30:15,960 --> 00:30:18,240
Yeah. You put that in a patient journey.
715
00:30:18,240 --> 00:30:20,580
I think that's an exercise
after clinical trials
716
00:30:20,580 --> 00:30:22,803
that the medical teams are doing.
717
00:30:23,880 --> 00:30:27,270
And at some point it's being discussed
718
00:30:27,270 --> 00:30:29,790
with our teams as well,
with market access,
719
00:30:29,790 --> 00:30:32,040
with the commercial and marketing teams.
720
00:30:32,040 --> 00:30:36,930
And that analyze of that
customer patient journey
721
00:30:36,930 --> 00:30:40,140
is really important more
than ever in rare diseases.
722
00:30:40,140 --> 00:30:42,630
As I said, many specialties are involved
723
00:30:42,630 --> 00:30:46,500
that patient is going,
yeah, going through a lot
724
00:30:46,500 --> 00:30:49,500
so I think it's really important
to analyze that afterwards.
725
00:30:49,500 --> 00:30:54,060
Again, you know what your
treatment or product can offer.
726
00:30:54,060 --> 00:30:57,000
If you want to have then better
tactics afterwards in place,
727
00:30:57,000 --> 00:30:57,990
better key messages
728
00:30:57,990 --> 00:31:00,870
towards your stakeholders you engage with.
729
00:31:00,870 --> 00:31:04,200
It's super crucial to
analyze that really in that.
730
00:31:04,200 --> 00:31:05,033
- Thanks.
731
00:31:06,360 --> 00:31:08,430
Now, I want to ask
probably one more question
732
00:31:08,430 --> 00:31:10,950
on looking forward, Andy.
- Yeah.
733
00:31:10,950 --> 00:31:14,460
- What do you think is the
next big thing in commercial,
734
00:31:14,460 --> 00:31:18,510
in rare diseases that we
should actually start doing?
735
00:31:18,510 --> 00:31:21,840
Let's start with a start question
736
00:31:21,840 --> 00:31:23,760
and then maybe with a stop question.
737
00:31:23,760 --> 00:31:25,770
So, what's the next big thing?
738
00:31:25,770 --> 00:31:28,413
- I think we should start doing,
739
00:31:29,700 --> 00:31:31,230
asking more feedback
740
00:31:31,230 --> 00:31:35,250
to the people we interact with even more.
741
00:31:35,250 --> 00:31:38,100
I think in advance we
are already doing that.
742
00:31:38,100 --> 00:31:39,593
I know you asked what start.
743
00:31:39,593 --> 00:31:42,720
I think keep on motivating to do so.
744
00:31:42,720 --> 00:31:45,360
Again, we all have, as representatives
745
00:31:45,360 --> 00:31:48,630
of pharmaceutical companies,
the responsibility
746
00:31:48,630 --> 00:31:52,530
to improve patient's life,
to impact patient's life.
747
00:31:52,530 --> 00:31:53,640
You need to have that in mind.
748
00:31:53,640 --> 00:31:55,680
So, I think that's why we need to start
749
00:31:55,680 --> 00:31:58,950
and keep on interacting with
the key stakeholders just
750
00:31:58,950 --> 00:32:02,130
to make sure we are doing
the right thing, yeah.
751
00:32:02,130 --> 00:32:04,083
- What would you stop doing?
752
00:32:05,100 --> 00:32:06,390
- Stop doing, and again,
753
00:32:06,390 --> 00:32:09,390
it's not necessarily something at ADVANZ,
754
00:32:09,390 --> 00:32:13,410
I think stop thinking
in the classical way.
755
00:32:13,410 --> 00:32:16,800
Classical way is we need
to interact x, y, z amount
756
00:32:16,800 --> 00:32:18,090
of times with our physicians.
757
00:32:18,090 --> 00:32:23,040
We need to give them x, y, z
amount of key messages across.
758
00:32:23,040 --> 00:32:24,990
That classic approach that we used to do
759
00:32:24,990 --> 00:32:28,140
in the earlier times, stop doing that.
760
00:32:28,140 --> 00:32:30,630
I think we also need to stop thinking,
761
00:32:30,630 --> 00:32:33,090
we need to put a multichannel
strategy in place
762
00:32:33,090 --> 00:32:35,730
and we need to enable these challenges.
763
00:32:35,730 --> 00:32:38,670
It's good to have multichannel,
omnichannel strategy
764
00:32:38,670 --> 00:32:41,490
in place, but again,
referring to what we need
765
00:32:41,490 --> 00:32:44,910
to start doing, ask feedback.
766
00:32:44,910 --> 00:32:46,290
Is it the preferred channel?
767
00:32:46,290 --> 00:32:48,600
Is it the preferred communications
768
00:32:48,600 --> 00:32:50,910
or key messages you're getting?
769
00:32:50,910 --> 00:32:53,760
So, for me it's as simple as that.
770
00:32:53,760 --> 00:32:57,900
And it's an exercise that
we do and that I would say
771
00:32:57,900 --> 00:33:00,990
every pharmaceutical
representative should do.
772
00:33:00,990 --> 00:33:03,030
- So, much more customer-centric-
773
00:33:03,030 --> 00:33:03,960
- Yes.
- In rare diseases.
774
00:33:03,960 --> 00:33:05,760
- Absolutely.
- Than maybe today.
775
00:33:05,760 --> 00:33:07,380
- Absolutely. Yeah, yeah.
- Okay.
776
00:33:07,380 --> 00:33:09,570
Andy, thank you so much for speaking
777
00:33:09,570 --> 00:33:10,830
with me today.
- It was a pleasure.
778
00:33:10,830 --> 00:33:12,720
- And for being here and for your time
779
00:33:12,720 --> 00:33:15,270
and I'm looking forward to
continue the conversation.
780
00:33:15,270 --> 00:33:16,680
- Absolutely. Anytime.
- Thank you.
781
00:33:16,680 --> 00:33:18,160
- Thank you very much.
- Thank you very much.
782
00:33:18,160 --> 00:33:21,327
(bright upbeat music)